Application
WZB-117 has been used to study its tumor initiating ability in cancer stem cells. It has also been used to study the effect of glucose antagonists on 2-NBDG (2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)Amino)-2-Deoxyglucose) uptake.
Biochem/physiol Actions
WBZ 117 is an inhibitor of basal glucose transport in H1299 lung and other cancer cells.
WZB-117 is an irreversible inhibitor. In cancer cells, WZB-117 prevents cell growth by stimulating apoptosis in any glucose concentration. It targets self-renewal and tumor-initiating capacity in cancer stem cells.
- UPC:
- 42202701
- Condition:
- New
- HazmatClass:
- No
- MPN:
- SML0621-5MG
- CAS:
- 1223397-11-2
akash.verma@cenmed.com
(732) 447-1115





